Read about the impact of the ACT-Accelerator and access the partnership's reports
Funding vital research and development of new therapeutics, vaccines, and diagnostics.
Delivering more than 160 million tests to over 180 countries
Supporting the market entry of new, affordable rapid tests.
Delivering more than 1.8 billion COVID-19 vaccine doses via the vaccines pillar, COVAX
Procuring over US$560 million worth of medical oxygen supplies and repairing 180 PSA plants
Read about the ACT-Accelerator's impact in our quarterly and annual reports: